Literature DB >> 16574892

Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway.

Kazutaka Ueda1, Hiroyuki Takano, Hiroshi Hasegawa, Yuriko Niitsuma, Yingjie Qin, Masashi Ohtsuka, Issei Komuro.   

Abstract

OBJECTIVE: Granulocyte colony stimulating factor (G-CSF) has been reported recently to prevent cardiac remodeling and dysfunction after acute myocardial infarction through signal transducer and activator of transcription 3 (STAT3). In this study, we examined acute effects of G-CSF on the heart against ischemia-reperfusion injury. METHODS AND
RESULTS: Rat hearts were subjected to global 35-minute ischemia and 120-minute reperfusion in Langendorff system with or without G-CSF (300 ng/mL). G-CSF administration was started at the onset of reperfusion. Triphenyltetrazolium chloride staining revealed that G-CSF markedly reduced the infarct size. G-CSF strongly activated Janus kinase 2 (Jak2), STAT3, extracellular signal-regulated kinase (ERK), Akt, and endothelial NO synthase (NOS) in the hearts subjected to ischemia followed by 15-minute reperfusion. The G-CSF-induced reduction in infarct size was abolished by inhibitors of phosphatidylinositol 3-kinase, Jak2, and NOS but not of mitogen-activated protein kinase kinase (MEK).
CONCLUSIONS: These results suggest that G-CSF acts directly on the myocardium during ischemia-reperfusion injury and has acute nongenomic cardioprotective effects through the Akt-endothelial NOS pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574892     DOI: 10.1161/01.ATV.0000219697.99134.10

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

Review 1.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

Authors:  Vincenzo Lionetti; Giacomo Bianchi; Fabio A Recchia; Carlo Ventura
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

2.  Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes.

Authors:  Mazen Kurdi; Vidhya Sivakumaran; Roy J Duhé; Miguel A Aon; Nazareno Paolocci; George W Booz
Journal:  Int J Biochem Cell Biol       Date:  2012-08-22       Impact factor: 5.085

Review 3.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

4.  Granulocyte colony-stimulating factor does not enhance recruitment of bone marrow-derived cells in rats with acute myocardial infarction.

Authors:  Daisuke Sato; Hajime Otani; Masanori Fujita; Takayuki Shimazu; Kei Yoshioka; Chiharu Enoki; Naoki Minato; Toshiji Iwasaka
Journal:  Exp Clin Cardiol       Date:  2012-09

5.  G-CSF and erythropoietin combination therapy for infarct repair: two plus two equals two? Editorial to: "Cytokine combination theray with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction" by F.S. Angeli et al.

Authors:  Carrie M Quinn; Buddhadeb Dawn
Journal:  Cardiovasc Drugs Ther       Date:  2010-12       Impact factor: 3.727

Review 6.  Relevance of nitric oxide for myocardial remodeling.

Authors:  Paul B Massion; Jean-Luc Balligand
Journal:  Curr Heart Fail Rep       Date:  2007-03

7.  Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury.

Authors:  Siamak Rahman; Jingyuan Li; Jean Chrisostome Bopassa; Soban Umar; Andrea Iorga; Parisa Partownavid; Mansoureh Eghbali
Journal:  Anesthesiology       Date:  2011-08       Impact factor: 7.892

Review 8.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

9.  Four cases of investigational therapy with interleukin-11 against acute myocardial infarction.

Authors:  Masashi Nakagawa; Yasuko Owada; Yasukatsu Izumi; Shinichi Nonin; Kenichi Sugioka; Daisaku Nakatani; Shinichi Iwata; Kazuki Mizutani; Satoshi Nishimura; Asahiro Ito; Suwako Fujita; Takashi Daimon; Yoshiki Sawa; Masanori Asakura; Makiko Maeda; Yasushi Fujio; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-01-21       Impact factor: 2.037

10.  Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.

Authors:  Britt N Fuglesteg; Naushaad Suleman; Crina Tiron; Tambuzai Kanhema; Lydia Lacerda; Thomas V Andreasen; Michael N Sack; Anne K Jonassen; Ole D Mjøs; Lionel H Opie; Sandrine Lecour
Journal:  Basic Res Cardiol       Date:  2008-05-23       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.